Market Overview

UPDATE: Cantor Fitzgerald Initiates Buy, $43 on Walgreen Post Express Scripts Contract Resolution

Share:
Related WAG
The 'Hateful' Eight: 8 Stocks Institutional Investors Dumped Last Quarter
Jim Cramer Shares His Thoughts On Bank Of America, Walgreens & Delta

Cantor Fitzgerald initiated its coverage on Walgreen (NYSE: WAG) with a Buy rating and a price target of $43.

Cantor Fitzgerald noted, "We expect 50% recovery of the lost script volume by FY:13. The combination of synergies from Alliance Boots, impact from generics, contribution from the USA Drug acquisition, and the benefits of an aging store fleet should be accretive by close to $0.30 per share in FY:13. We prefer to be conservative in our assumptions for ESRX and assume that marketing expenses are likely to offset $0.11-$0.12 per share benefit from recaptured ESRX scripts in FY:13. If customer re-activation costs are lower than our expectations, or if Walgreen's is able to recapture a higher portion of ESRX customers relative to our assumption, we see potential for further upside.."

Walgreen closed at $35.44 on Tuesday.

Latest Ratings for WAG

DateFirmActionFromTo
Dec 2014BarclaysMaintainsEqual-weight
Dec 2014JP MorganMaintainsOverweight
Dec 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→